Moreover, elevated sclerostin levels have been consistently associated with vascular calcification, particularly in patients with chronic kidney disease (CKD) and diabetes, both of which are conditions that exacerbate cardiovascular risk [18,19,20,21]. This evidence concerns the gene SOST and chronic kidney disease.